LABU vs XBIX: Leverage, Returns & Decay
Over three months to Nov 13, 2026, against its daily multiple, compounded, LABU finished 2.0 points short and XBIX 2.6 points short.
- Return gap
- +8.4 pts3 months to Nov 13, 2026: XBIX ahead, total return
- Fee gap
- 0.51 ptsA year: LABU 0.96%, XBIX 0.45%, per filings dated Mar 3, 2026 and Jun 11, 2026
- Overlap
- –No book read for both funds
- Net flow
- –Needs daily flows for both funds
Compare two other funds
Growth of 100
Drawn from the numbers on this page. Growth of 100, both funds, distributions reinvested
LABU −22.3%, XBIX −13.9%: XBIX +8.4 pts ahead, 3 months, Aug 14, 2026 to Nov 13, 2026.
ShareUse this comparison
Fees over time
Hypothetical. $10,000 in LABU for 10 years at 0.96% a year costs about $1,557 in fees and lost growth; XBIX at 0.45% would cost $746. Assumes 6% a year before fees, a sample rate, not a forecast.
How each fund moved
LABU returned −22.3% while 3 times XBI's move would have been −13.2%. Data from Aug 14, 2026 to Nov 13, 2026.
Data from Aug 14, 2026 to Nov 13, 2026.XBIX returned −13.9% while 2 times XBI's move would have been −8.8%. Data from Aug 14, 2026 to Nov 13, 2026.
XBIX returned −13.9% while 2 times XBI's move would have been −8.8%. Data from Aug 14, 2026 to Nov 13, 2026.IQ Leverage Score
How closely it delivered its daily multiple over 3 months, ranked against 31 leveraged ETFs at 3x, over three months and 498 leveraged ETFs at 2x, over three months. 100 is best.
LABU scores higher · Did it keep up with its own daily multiple, compounded day by day, over three months?
LABU among the 31 leveraged ETFs at 3x, over three months
XBIX among the 498 leveraged ETFs at 2x, over three months
A percentile among the 31 leveraged ETFs at 3x, over three months. XBIX is a percentile among the 498 leveraged ETFs at 2x, over three months, a different set, so the two marks are not on one scale. Three months only, against the fund's own daily multiple; a different quarter can rank it very differently.
Key numbers
XBIX costs 0.51 points a year less.
Pair scorecard
Open the table
Points (pts) are percentage points.
| Total return, 1 year | +70.3% | not published |
|---|---|---|
| What its daily multiple gave, 3 months | −20.3% | −11.3% |
| What it tracks | S&P Biotech | U.S. Biotech |
| Expense ratio | 0.96% | 0.45% |
| Net assets, as of Nov 12, 2026 | $540m | $317,675 |
| Holdings in common | not published |
The numbers behind it
Net assets: $540m on Nov 12, 2026 for Direxion Daily S&P Biotech Bull 3X ETF, and $314,629 on Nov 13, 2026 for Corgi U.S. Biotech 2x Daily ETF.
Side by side
Open the table
| Fund | Direxion Daily S&P Biotech Bull 3X ETF · Aims to return three times the daily move of biotech (XBI) | Corgi U.S. Biotech 2x Daily ETF · Aims to return twice the daily move of biotech (XBI) |
| Issuer | Direxion | Corgi |
| Sets out to return | +3x | +2x |
| Underlying asset | XBI | XBI |
| Segment | sector | sector |
| Fund returned, 3 months | −22.3% | −13.9% |
| Underlying returned, over that window | −4.4% | −4.4% |
| What the stated multiple implies, over that window | −13.2% | −8.8% |
| Difference from stated, over that window | −9.1 pts | −5.1 pts |
| Fund returned, 1 year | +70.3% | +22.0% (since launch, Jun 3, 2026) |
| Difference from stated, over that window | −35.0 pts | −10.2 pts (since launch, Jun 3, 2026) |
| Underlying volatility | 35% | 35% |
| Expense ratio | 0.96% | 0.45% |
| First traded | May 28, 2015 | Jun 3, 2026 |
| Net assets, LABU as of Nov 12, 2026 and XBIX as of Nov 13, 2026 | $540m | $314,629 |
As of Nov 13, 2026. Source: ETFIQ.
Window by window
Open the full table
| 1 month | +2.3% | +2.8% | +7.8% | +5.2% | −5.5 pts | −2.4 pts |
|---|---|---|---|---|---|---|
| 3 months | −22.3% | −13.9% | −13.2% | −8.8% | −9.1 pts | −5.1 pts |
| 6 months | +24.5% | – | +45.9% | – | −21.4 pts | – |
| 1 year | +70.3% | – | +105.3% | – | −35.0 pts | – |
| 3 years | +238.0% | – | not meaningful | – | not meaningful | – |
| Since launch (Not the same days: LABU May 2015 · XBIX Jun 2026) | −93.0% | +22.0% | +285.0% | +32.2% | −378.0 pts | −10.2 pts |
– means no data for this window.
About LABU
Over the three months to Nov 13, 2026, LABU lost 22.3%, against −20.3% for three times XBI's daily moves. Read the multiple against the whole window instead and 3 times XBI's −4.4% implies −13.2%, which makes LABU look 9.1 points short. That is not the fund's objective, which is daily. Of that 9.1, daily compounding is −7.1 points, which any 3 times fund would show over the same path, and the fund itself is −2.0 points against 3 times each day's move, compounded. LABU aims to return +3 times XBI's move each day, then resets. Over one day it does that. Over longer periods the daily results compound, so the total is not +3 times the period's move: it is lower after a fall and recovery, and can be higher in a steady run. XBI moved at 35% annualized over that window. The more it moves, the further the two numbers separate.
About XBIX
Over the three months to Nov 13, 2026, XBIX lost 13.9%, against −11.3% for twice XBI's daily moves. Read the multiple against the whole window instead and 2 times XBI's −4.4% implies −8.8%, which makes XBIX look 5.1 points short. Of that 5.1, daily compounding is −2.5 points, which any 2 times fund would show over the same path, and the fund itself is −2.6 points against 2 times each day's move, compounded. XBIX aims to return +2 times XBI's move each day, then resets. Over longer periods the daily results compound, so the total is not +2 times the period's move: it is lower after a fall and recovery, and can be higher in a steady run.
Questions people ask
Which came closer to its daily multiple, LABU or XBIX?
Over the window to Nov 13, 2026, LABU finished 9.1 points from what its multiple implies and XBIX finished 5.1 points from its own, so XBIX came closer. Neither number predicts the next window: it depends on how much the underlying moves about.
Are LABU and XBIX levered on the same thing?
Yes. Both are levered on biotech, LABU at +3 times and XBIX at +2 times the daily move.
Which one decays faster, LABU or XBIX?
Decay follows how much the underlying moves about. Over this window LABU’s moved at 35% annualized and XBIX’s at 35%, so LABU has the rougher ride and, at the same multiple, loses more to compounding.
Can I hold LABU or XBIX for a year?
Both reset every day, so the multiple in the name applies to a single day, and daily results compound. Over a year the total is not the multiple times the year’s move; after a fall and recovery it is lower.
Other comparisons
Sources
More
Links are sources, not endorsements. A comparison is not a recommendation.
Copy and cite
Cite this pageCitation, APA and Markdown
ETFIQ, LABU against XBIX, data as of Nov 13, 2026. https://etfiq.com/compare/leverage/labu-vs-xbix
ETFIQ. (Nov 13, 2026). LABU against XBIX. Retrieved from https://etfiq.com/compare/leverage/labu-vs-xbix
[LABU against XBIX (ETFIQ, Nov 13, 2026)](https://etfiq.com/compare/leverage/labu-vs-xbix)
Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.